Back

Long term outcome: ST-2 and/or adrenomedulin.

1 May 2017 (14:51 - 15:09)
Organised by:
Congress Presentation Part of: Biomarkers in chronic heart failure Biomarkers HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Professor Hans-Peter Brunner-La Rocca

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Natrurietic peptide-guided therapy: a curvy road ahead.
Professor M. Richards (Christchurch, NZ)
Slides Video
Presentation thumbnail
New markers of acute kidney injury.
Doctor M. Costanzo (Naperville, US)
Slides Video
Presentation thumbnail
What is in the pipeline?
Professor A. Maisel (San Diego, US)
Slides Video
Presentation thumbnail
Biomarkers changed my daily practice!
Professor R. De Boer (Rotterdam, NL)
Slides Video

Access the full session

Session thumbnail
Biomarkers in chronic heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 14:51 CET
You may be interested in
thumbnail
Congress Presentation
Head-to-head comparison of NT-proBNP and soluble ST2 for long-term prognosis of patients with hypertrophic cardiomyopathy
27 August 2021
thumbnail
Congress Presentation
The adrenomedullin system predicts cardiogenic shock in acute coronary syndromes
30 August 2026
thumbnail
Congress Presentation
Is there still a role for neurohormonal therapy in patients with STEMI and mildly reduced ejection
22 May 2023
thumbnail
Congress Presentation
Long-term prognostic value of stress echocardiography in patients with suspected coronary artery disease - Systematic review and meta-analysis
12 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources